BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 33883194)

  • 1. Genetic Risk Factors for CVD in Type 1 Diabetes: The DCCT/EDIC Study.
    Bebu I; Keshavarzi S; Gao X; Braffett BH; Canty AJ; Herman WH; Orchard TJ; Dagogo-Jack S; Nathan DM; Lachin JM; Paterson AD;
    Diabetes Care; 2021 Jun; 44(6):1309-1316. PubMed ID: 33883194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk Factors for First and Subsequent CVD Events in Type 1 Diabetes: The DCCT/EDIC Study.
    Bebu I; Schade D; Braffett B; Kosiborod M; Lopes-Virella M; Soliman EZ; Herman WH; Bluemke DA; Wallia A; Orchard T; Lachin JM;
    Diabetes Care; 2020 Apr; 43(4):867-874. PubMed ID: 32001614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Moderation of the effect of glycemia on the risk of cardiovascular disease in type 1 diabetes: The DCCT/EDIC study.
    Bebu I; Braffett BH; Orchard TJ; Lorenzi GM; Nathan DM; Herman WH; Lachin JM
    Diabetes Res Clin Pract; 2021 Jan; 171():108591. PubMed ID: 33310124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Associations of Microvascular Complications With the Risk of Cardiovascular Disease in Type 1 Diabetes.
    Gubitosi-Klug R; Gao X; Pop-Busui R; de Boer IH; White N; Aiello LP; Miller R; Palmer J; Tamborlane W; Wallia A; Kosiborod M; Lachin JM; Bebu I;
    Diabetes Care; 2021 Jul; 44(7):1499-1505. PubMed ID: 33980605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Association of Coronary Artery Calcification With Subsequent Incidence of Cardiovascular Disease in Type 1 Diabetes: The DCCT/EDIC Trials.
    Budoff M; Backlund JC; Bluemke DA; Polak J; Bebu I; Schade D; Strowig S; Raskin P; Lachin JM;
    JACC Cardiovasc Imaging; 2019 Jul; 12(7 Pt 2):1341-1349. PubMed ID: 30878435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular Autonomic Neuropathy and Cardiovascular Outcomes in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study.
    Pop-Busui R; Braffett BH; Zinman B; Martin C; White NH; Herman WH; Genuth S; Gubitosi-Klug R;
    Diabetes Care; 2017 Jan; 40(1):94-100. PubMed ID: 27803120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longitudinal Plasma Kallikrein Levels and Their Association With the Risk of Cardiovascular Disease Outcomes in Type 1 Diabetes in DCCT/EDIC.
    Jaffa MA; Bebu I; Luttrell D; Braffett BH; Lachin JM; Hunt K; Lopes-Virella M; Luttrell L; Lyons TJ; Jaffa AA;
    Diabetes; 2020 Nov; 69(11):2440-2445. PubMed ID: 32826295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk Factor Modeling for Cardiovascular Disease in Type 1 Diabetes in the Pittsburgh Epidemiology of Diabetes Complications (EDC) Study: A Comparison With the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study (DCCT/EDIC).
    Miller RG; Costacou T; Orchard TJ
    Diabetes; 2019 Feb; 68(2):409-419. PubMed ID: 30409781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electrocardiographic Abnormalities and Cardiovascular Disease Risk in Type 1 Diabetes: The Epidemiology of Diabetes Interventions and Complications (EDIC) Study.
    Soliman EZ; Backlund JC; Bebu I; Orchard TJ; Zinman B; Lachin JM;
    Diabetes Care; 2017 Jun; 40(6):793-799. PubMed ID: 28302651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk Factors for Cardiovascular Disease in Type 1 Diabetes.
    Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Research Group
    Diabetes; 2016 May; 65(5):1370-9. PubMed ID: 26895792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk Factors for Longitudinal Resting Heart Rate and Its Associations With Cardiovascular Outcomes in the DCCT/EDIC Study.
    Keshavarzi S; Braffett BH; Pop-Busui R; Orchard TJ; Soliman EZ; Lorenzi GM; Barnie A; Karger AB; Gubitosi-Klug RA; Dagogo-Jack S; Paterson AD;
    Diabetes Care; 2021 May; 44(5):1125-1132. PubMed ID: 33632724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mediation of the Effect of Glycemia on the Risk of CVD Outcomes in Type 1 Diabetes: The DCCT/EDIC Study.
    Bebu I; Braffett BH; Orchard TJ; Lorenzi GM; Lachin JM;
    Diabetes Care; 2019 Jul; 42(7):1284-1289. PubMed ID: 30894365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intensive Diabetes Treatment and Cardiovascular Outcomes in Type 1 Diabetes: The DCCT/EDIC Study 30-Year Follow-up.
    Diabetes Control and Complications Trial (DCCT)/Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Group
    Diabetes Care; 2016 May; 39(5):686-93. PubMed ID: 26861924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum urate and cardiovascular events in the DCCT/EDIC study.
    Jenkins AJ; Braffett BH; Basu A; Bebu I; Dagogo-Jack S; Orchard TJ; Wallia A; Lopes-Virella MF; Garvey WT; Lachin JM; Lyons TJ;
    Sci Rep; 2021 Jul; 11(1):14182. PubMed ID: 34244538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycemic Control, Cardiac Autoimmunity, and Long-Term Risk of Cardiovascular Disease in Type 1 Diabetes Mellitus.
    Sousa GR; Pober D; Galderisi A; Lv H; Yu L; Pereira AC; Doria A; Kosiborod M; Lipes MA
    Circulation; 2019 Feb; 139(6):730-743. PubMed ID: 30586738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Body-weight variability and risk of cardiovascular outcomes in patients with type 1 diabetes: a retrospective observational analysis of data from the DCCT/EDIC population.
    Petria I; Albuquerque S; Varoquaux G; Vie JJ; Venteclef N; Mohammedi K; Roussel R; Camoin M; Perseghin G; Velho G; Potier L
    Cardiovasc Diabetol; 2022 Nov; 21(1):247. PubMed ID: 36397092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Excessive Weight Gain on Cardiovascular Outcomes in Type 1 Diabetes: Results From the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study.
    Purnell JQ; Braffett BH; Zinman B; Gubitosi-Klug RA; Sivitz W; Bantle JP; Ziegler G; Cleary PA; Brunzell JD;
    Diabetes Care; 2017 Dec; 40(12):1756-1762. PubMed ID: 29138273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of Insulin Dose, Cardiometabolic Risk Factors, and Cardiovascular Disease in Type 1 Diabetes During 30 Years of Follow-up in the DCCT/EDIC Study.
    Braffett BH; Dagogo-Jack S; Bebu I; Sivitz WI; Larkin M; Kolterman O; Lachin JM;
    Diabetes Care; 2019 Apr; 42(4):657-664. PubMed ID: 30728218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors differ by first manifestation of cardiovascular disease in type 1 diabetes.
    Miller RG; Orchard TJ; Costacou T
    Diabetes Res Clin Pract; 2020 May; 163():108141. PubMed ID: 32277955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA methylation and 28-year cardiovascular disease risk in type 1 diabetes: the Epidemiology of Diabetes Complications (EDC) cohort study.
    Miller RG; Mychaleckyj JC; Onengut-Gumuscu S; Feingold E; Orchard TJ; Costacou T
    Clin Epigenetics; 2023 Aug; 15(1):122. PubMed ID: 37533055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.